United States· US:84610-300_48c8100d-5b29-ea3e-e063-6294a90ab076
ANUA INVISIBLE GLOW FINISH SUNSCREEN
A medicinal product containing octocrylene; avobenzone; octisalate; homosalate, registered in United States by The Founders Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTOCRYLENE; AVOBENZONE; OCTISALATE; HOMOSALATE
- Manufacturer
- The Founders Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11846103000117.5 g in 1 BOTTLE (84610-300-01)
- ndc1184610-300-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2b3371ca-3bc6-4db0-b57c-1841a2ec1b1d GET /v1/drugs/2b3371ca-3bc6-4db0-b57c-1841a2ec1b1d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "5; 2.7; 4.5; 9.5",
"substance": "OCTOCRYLENE; AVOBENZONE; OCTISALATE; HOMOSALATE",
"productndc": "84610-300",
"dosage_form": "STICK",
"dea_schedule": null,
"strength_unit": "g/100g; g/100g; g/100g; g/100g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octocrylene; avobenzone; octisalate; homosalate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.